Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Xiogenix, an innovator in cell and gene therapy downstream process automation, today ...
Officials at Autolomous and Cellular Origins say the companies have carried out the end-to-end integration of their respective platforms to bring full automation and digitization to the entire cell ...
After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have opened for Cellares, the automated cell therapy manufacturing specialist’s ...
SurvivorNet on MSN
Allogene CEO Zach Roberts is pushing to make CAR T-cell therapy more accessible: 'That's what gets me out of bed'
Allogene Therapeutics CEO Zach Roberts discusses his work advancing groundbreaking CAR T-cell therapy and his vision for ...
Cell therapy, one of the most promising frontiers in modern medicine, holds the potential to cure once-incurable diseases such as cancer and genetic disorders. But for all its promise, manufacturing ...
Bracco Imaging has launched the BubbleGen CD3+ T Cell Selection Kit, extending its microbubble-based, magnetic bead-free ...
Hosted on MSN
Inside a cell therapy manufacturing facility: How Iovance turns a patient’s immune cells into treatment
Rusty Konkol wanted to hug everyone he saw during his tour of Iovance Biotherapeutics’ Navy Yard manufacturing facility. The 71-year-old grandfather with metastatic melanoma had flown in from ...
Cell and gene therapies (CGTs) are built on living systems. From early research through commercial distribution, the integrity of those systems depends on the ability to preserve cells without ...
The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies. The modular Eveo Cell Therapy Platform is designed to ...
Personalized cell therapies have emerged as powerful treatments for cancers and other diseases but producing them remains a complex engineering challenge. Unlike conventional drugs, each cell therapy ...
Cell and gene therapy manufacturing relies on complex cell processing, viral vector production, quality control, and GMP-compliant workflows to consistently produce safe and effective therapies at ...
In this innovation spotlight, Tia Harmon, technical science liaison, CGT for PHC Corporation of North America (PHCNA), discusses the key challenges in CGT manufacturing and how in-line monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results